+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biotechnology Instrument Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142059
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biotechnology Instrument Market is projected to reach USD 10.63 Billion in 2026. It is expected to continue growing at a CAGR of 9.45%, reaching USD 18.21 Billion by 2032.

Biotechnology Instruments: Executive Overview

Biotechnology instruments support the measurement, analysis, preparation, and quality control of biological materials across research, diagnostics, bioprocessing, and biomanufacturing. The landscape is shaped by demand for reproducible results, faster workflows, stronger data integrity, and compatibility with increasingly complex biological systems. Adoption decisions increasingly depend on performance in real laboratory environments, including usability, maintenance, interoperability, regulatory documentation, and the availability of technical support.

Workflow Integration Is Reshaping Biotechnology Instrumentation

The sector is moving from stand-alone equipment toward connected workflows that combine instruments, consumables, software, automation, and laboratory information systems. Laboratories are prioritizing modular platforms that can be upgraded as protocols evolve, while bioprocess operators emphasize repeatability, contamination control, and scale-appropriate process monitoring. Standardization, remote service capabilities, cybersecurity, and validation documentation are becoming more important as organizations coordinate work across sites and seek consistent operating procedures.

Artificial Intelligence Improves Instrument Utilization and Biological Insight

Artificial intelligence is increasingly applied to image interpretation, signal classification, anomaly detection, protocol optimization, predictive maintenance, and automated quality review. Its cumulative effect is strongest when models are integrated with reliable instrumentation, well-curated datasets, and traceable laboratory records. However, adoption remains dependent on validation, explainability, data governance, cybersecurity, and the ability of laboratory professionals to review and override automated decisions. AI therefore complements-not replaces-the need for robust experimental design and instrument quality controls.

Regional Insights: Infrastructure and Regulatory Readiness Shape Adoption

North America benefits from strong research, clinical, and biomanufacturing infrastructure, with purchasing decisions influenced by automation, compliance, and interoperability. Europe places strong emphasis on data integrity, sustainability, quality systems, and cross-border regulatory alignment. Asia-Pacific combines advanced innovation hubs with rapidly expanding laboratory capacity, creating demand for scalable and adaptable platforms. Latin America is influenced by public-health priorities, import logistics, technical training, and the availability of local service support. The Middle East is investing in research, diagnostics, and specialized healthcare infrastructure, while Africa’s adoption is closely linked to affordability, resilient supply chains, workforce development, and dependable maintenance access.

Group Insights: Cooperation and Standards Influence Instrument Strategies

ASEAN economies show varied levels of laboratory maturity, making flexible platforms, regional service networks, and workforce training particularly relevant. BRICS members reflect diverse scientific and industrial priorities, with interest in domestic capability, technology transfer, and supply-chain resilience. The European Union emphasizes harmonized regulation, sustainability, research collaboration, and interoperable data practices. G7 members generally prioritize high performance, advanced automation, cybersecurity, and rigorous validation. GCC countries are strengthening research and healthcare capacity through centralized investments and partnerships, while NATO members place additional emphasis on secure supply chains, preparedness, dual-use research governance, and operational resilience.

Country Insights: Diverse Priorities Across Key Biotechnology Markets

Australia emphasizes research quality, biosecurity, and geographically resilient service models. Brazil combines substantial agricultural, health, and research needs with sensitivity to import complexity and local support. Canada prioritizes life-science research, advanced healthcare applications, and collaboration across public and private institutions. China is strengthening domestic biotechnology capabilities while pursuing automation and manufacturing self-reliance. France and Germany emphasize regulated quality, industrial biotechnology, and research infrastructure; Italy and Spain show continued relevance of academic, clinical, and specialized industrial laboratories. India is expanding affordable, scalable laboratory capacity and domestic production. Japan and South Korea focus on precision, automation, advanced manufacturing, and high-quality process control. Mexico’s opportunity is tied to healthcare, industrial development, and regional supply-chain integration. Russia’s instrument environment is shaped by domestic capability, access constraints, and institutional continuity. The United Kingdom and United States remain influential through advanced research, clinical innovation, and strong demand for integrated, data-rich workflows.

Action Priorities for Biotechnology Instrument Leaders

Industry leaders should design modular systems that support evolving assays, automation, and software integration without forcing complete platform replacement. They should build measurable value around reproducibility, throughput, uptime, total operating effort, and regulatory readiness rather than relying solely on technical specifications. AI features should be introduced with transparent validation, human oversight, audit trails, and secure data architecture. Regional execution should include localized applications support, dependable spare-parts access, training programs, and partnerships that address infrastructure differences. Finally, resilient sourcing, sustainability-by-design, interoperable data formats, and lifecycle service capabilities should be treated as core product requirements.

Research Methodology for the Executive Summary

This executive summary is based on a structured qualitative assessment of biotechnology instrumentation and its principal adoption drivers. The analysis considers instrument roles across research, diagnostics, bioprocessing, and biomanufacturing; evaluates effects from automation, connectivity, artificial intelligence, regulation, skills, and supply-chain conditions; and compares implications across the specified regions, country groups, and countries. No market estimates, market shares, forecasts, or company-specific claims are used. Conclusions are framed as evidence-based strategic themes rather than numerical market projections.

Conclusion: Reliability, Integration, and Resilience Define Future Competitiveness

Biotechnology instruments are becoming central components of connected, data-intensive, and increasingly automated biological workflows. Competitive advantage will depend on combining analytical performance with dependable operation, validated software, secure connectivity, strong service coverage, and compatibility with changing regulatory and scientific requirements. Organizations that align technology selection with workforce capability, infrastructure realities, and long-term workflow resilience will be better positioned to convert instrumentation into consistent biological and operational outcomes.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biotechnology Instrument Market, by Instrument Type
7.1. Introduction
7.2. Cell Culture Systems
7.2.1. Bioreactors
7.2.2. Cell Counters
7.2.3. Incubators
7.3. Chromatography Systems
7.3.1. GC Systems
7.3.2. HPLC Systems
7.3.2.1. Analytical HPLC
7.3.2.2. Preparative HPLC
7.3.3. UHPLC Systems
7.4. Mass Spectrometers
7.4.1. Ion Trap MS
7.4.2. Orbitrap MS
7.4.3. Quadrupole MS
7.4.4. Time-of-Flight MS
7.5. PCR Systems
7.5.1. Conventional PCR
7.5.2. Digital PCR
7.5.3. Real-Time PCR
7.6. Sequencing Systems
7.6.1. Next-Gen Sequencers
7.6.2. Sanger Sequencers
7.6.3. Third-Gen Sequencers
8. Biotechnology Instrument Market, by Technology
8.1. Introduction
8.2. Electrochemical Detection
8.2.1. Amperometric Detection
8.2.2. Potentiometric Detection
8.2.3. Voltammetric Detection
8.3. Flow Cytometry
8.3.1. Cell Counting
8.3.2. Cell Sorting
8.3.3. Phenotyping
8.4. Microarray Technology
8.4.1. DNA Microarray
8.4.2. Protein Microarray
8.4.3. Tissue Microarray
8.5. Optical Imaging
8.5.1. Bioluminescence Imaging
8.5.2. Confocal Microscopy
8.5.3. Fluorescence Imaging
8.6. Sequencing Technology
8.6.1. Next-Gen Sequencing
8.6.2. Sanger Sequencing
8.6.3. Single-Cell Sequencing
8.6.4. Third-Gen Sequencing
9. Biotechnology Instrument Market, by Application
9.1. Introduction
9.2. Cell Biology
9.2.1. Cell Counting
9.2.2. Cell Imaging
9.2.3. Cell Sorting
9.3. Diagnostics
9.3.1. Cancer Diagnostics
9.3.2. Genetic Testing
9.3.3. Infectious Disease Diagnostics
9.4. Drug Discovery
9.4.1. Lead Optimization
9.4.2. Preclinical Research
9.4.3. Target Identification
9.5. Genomics
9.5.1. Epigenetics
9.5.2. Gene Expression Analysis
9.5.3. SNP Genotyping
9.6. Proteomics
9.6.1. Protein Identification
9.6.2. Protein Interaction Analysis
9.6.3. Protein Quantification
10. Biotechnology Instrument Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Government Research Labs
10.2.2. University Labs
10.3. Contract Research Organizations
10.3.1. Clinical CROs
10.3.2. Preclinical CROs
10.4. Hospitals & Clinics
10.4.1. Clinical Research Labs
10.4.2. Diagnostic Labs
10.5. Pharma & Biotech Companies
11. Biotechnology Instrument Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Biotechnology Instrument Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Biotechnology Instrument Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Agilent Technologies, Inc.
15.2. Amgen Inc.
15.3. Bausch + Ströbel SE
15.4. Becton, Dickinson and Company
15.5. Bio-Rad Laboratories, Inc.
15.6. bioMérieux SA
15.7. Danaher Corporation
15.8. Eppendorf SE
15.9. F. Hoffmann-La Roche Ltd.
15.10. Gilead Sciences, Inc.
15.11. Illumina, Inc.
15.12. Johnson & Johnson Services, Inc.
15.13. Merck KGaA
15.14. QIAGEN N.V.
15.15. Revvity, Inc.
15.16. Sartorius AG
15.17. Tecan Group Ltd.
15.18. Thermo Fisher Scientific Inc.
15.19. Waters Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biotechnology Instrument Market, Years Considered for the Study
FIGURE 2. Global Biotechnology Instrument Market, Research Design
FIGURE 3. Global Biotechnology Instrument Market, Research Framework
FIGURE 4. Global Biotechnology Instrument Market, Data Triangulation
FIGURE 5. Global Biotechnology Instrument Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biotechnology Instrument Market Size, by Instrument Type, 2025 vs 2032 (%)
FIGURE 7. Global Biotechnology Instrument Market Size, by Instrument Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biotechnology Instrument Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Biotechnology Instrument Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biotechnology Instrument Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Biotechnology Instrument Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biotechnology Instrument Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Biotechnology Instrument Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biotechnology Instrument Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Biotechnology Instrument Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biotechnology Instrument Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Biotechnology Instrument Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Biotechnology Instrument Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biotechnology Instrument Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biotechnology Instrument Market Segmentation & Coverage
TABLE 2. Global Biotechnology Instrument Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biotechnology Instrument Market Size, by Instrument Type, 2017-2032 (USD Million)
TABLE 4. Global Cell Culture Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cell Culture Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cell Culture Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cell Counters Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cell Counters Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cell Counters Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Incubators Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Incubators Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Incubators Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Chromatography Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Chromatography Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Chromatography Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global GC Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global GC Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global GC Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global HPLC Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global HPLC Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global HPLC Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Analytical HPLC Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Analytical HPLC Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Analytical HPLC Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Preparative HPLC Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Preparative HPLC Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Preparative HPLC Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global UHPLC Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global UHPLC Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global UHPLC Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Mass Spectrometers Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Mass Spectrometers Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Mass Spectrometers Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Ion Trap MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Ion Trap MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Ion Trap MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Orbitrap MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Orbitrap MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Orbitrap MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Quadrupole MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Quadrupole MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Quadrupole MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Time-of-Flight MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Time-of-Flight MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Time-of-Flight MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global PCR Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global PCR Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global PCR Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Conventional PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Conventional PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Conventional PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Real-Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Real-Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Real-Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Sequencing Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Sequencing Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Sequencing Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Next-Gen Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Next-Gen Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Next-Gen Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Sanger Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Third-Gen Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Third-Gen Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Third-Gen Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Biotechnology Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 74. Global Electrochemical Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Electrochemical Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Electrochemical Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Amperometric Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Amperometric Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Amperometric Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Potentiometric Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Potentiometric Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Potentiometric Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Voltammetric Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Voltammetric Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Voltammetric Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Cell Counting Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Cell Counting Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Cell Counting Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Cell Sorting Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Cell Sorting Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Cell Sorting Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Phenotyping Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Phenotyping Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Phenotyping Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Microarray Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Microarray Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Microarray Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global DNA Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global DNA Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global DNA Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Protein Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Protein Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Protein Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Tissue Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Tissue Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Tissue Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Optical Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Optical Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Optical Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Bioluminescence Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Bioluminescence Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Bioluminescence Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Confocal Microscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Confocal Microscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Confocal Microscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Fluorescence Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Fluorescence Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Fluorescence Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Sequencing Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Sequencing Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Sequencing Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Next-Gen Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Next-Gen Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Next-Gen Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Sanger Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Sanger Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Sanger Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Single-Cell Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Single-Cell Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Single-Cell Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Third-Gen Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Third-Gen Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Third-Gen Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Biotechnology Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Global Cell Biology Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Cell Biology Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Cell Biology Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Cell Counting Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Cell Counting Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Cell Counting Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Cell Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Cell Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Cell Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Cell Sorting Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Cell Sorting Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Cell Sorting Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Cancer Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Cancer Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Cancer Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Infectious Disease Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Infectious Disease Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Infectious Disease Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Lead Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Lead Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Lead Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Preclinical Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Preclinical Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Preclinical Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Target Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Global Target Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. Global Target Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. Global Genomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Genomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Genomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Epigenetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Epigenetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Epigenetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Gene Expression Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Gene Expression Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Gene Expression Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global SNP Genotyping Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global SNP Genotyping Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global SNP Genotyping Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Proteomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Proteomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Proteomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Protein Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Protein Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Protein Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Protein Interaction Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Protein Interaction Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Protein Interaction Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global Protein Quantification Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Global Protein Quantification Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. Global Protein Quantification Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. Global Biotechnology Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 202. Global Government Research Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Global Government Research Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. Global Government Research Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. Global University Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Global University Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. Global University Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 208. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 211. Global Clinical CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Global Clinical CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. Global Clinical CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 214. Global Preclinical CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 215. Global Preclinical CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. Global Preclinical CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 217. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 218. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 220. Global Clinical Research Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 221. Global Clinical Research Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. Global Clinical Research Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 223. Global Diagnostic Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 224. Global Diagnostic Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. Global Diagnostic Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 226. Global Pharma & Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 227. Global Pharma & Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 228. Global Pharma & Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 229. Global Biotechnology Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 230. Asia-Pacific Biotechnology Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Asia-Pacific Biotechnology Instrument Market Size, by Instrument Type, 2017-2032 (USD Million)
TABLE 232. Asia-Pacific Biotechnology Instrument Market Size, by Cell Culture Systems, 2017-2032 (USD Million)
TABLE 233. Asia-Pacific Biotechnology Instrument Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 234. Asia-Pacific Biotechnology Instrument Market Size, by HPLC Systems, 2017-2032 (USD Million)
TABLE 235. Asia-Pacific Biotechnology Instrument Market Size, by Mass Spectrometers, 2017-2032 (USD Million)
TABLE 236. Asia-Pacific Biotechnology Instrument Market Size, by PCR Systems, 2017-2032 (USD Million)
TABLE 237. Asia-Pacific Biotechnology Instrument Market Size, by Sequencing Systems, 2017-2032 (USD Million)
TABLE 238. Asia-Pacific Biotechnology Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 239. Asia-Pacific Biotechnology Instrument Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 240. Asia-Pacific Biotechnology Instrument Market Size, by Flow Cytometry, 2017-2032 (USD Million)
TABLE 241. Asia-Pacific Biotechnology Instrument Market Size, by Microarray Technology, 2017-2032 (USD Million)
TABLE 242. Asia-Pacific Biotechnology Instrument Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 243. Asia-Pacific Biotechnology Instrument Market Size, by Sequencing Technology, 2017-2032 (USD Million)
TABLE 244. Asia-Pacific Biotechnology Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Asia-Pacific Biotechnology Instrument Market Size, by Cell Biology, 2017-2032 (USD Million)
TABLE 246. Asia-Pacific Biotechnology Instrument Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 247. Asia-Pacific Biotechnology Instrument Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 248. Asia-Pacific Biotechnology Instrument Market Size, by Genomics, 2017-2032 (USD Million)
TABLE 249. Asia-Pacific Biotechnology Instrument Market Size, by Proteomics, 2017-2032 (USD Million)
TABLE 250. Asia-Pacific Biotechnology Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. Asia-Pacific Biotechnology Instrument Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 252. Asia-Pacific Biotechnology Instrument Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 253. Asia-Pacific Biotechnology Instrument Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 254. North America Biotechnology Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 255. North America Biotechnology Instrument Market Size, by Instrument Type, 2017-2032 (USD Million)
TABLE 256. North America Biotechnology Instrument Market Size, by Cell Culture Systems, 2017-2032 (USD Million)
TABLE 257. North America Biotechnology Instrument Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 258. North America Biotechnology Instrument Market Size, by HPLC Systems, 2017-2032 (USD Million)
TABLE 259. North America Biotechnology Instrument Market Size, by Mass Spectrometers, 2017-2032 (USD Million)
TABLE 260. North America Biotechnology Instrument Market Size, by PCR Systems, 2017-2032 (USD Million)
TABLE 261. North America Biotechnology Instrument Market Size, by Sequencing Systems, 2017-2032 (USD Million)
TABLE 262. North America Biotechnology Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 263. North America Biotechnology Instrument Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 264. North America Biotechnology Instrument Market Size, by Flow Cytometry, 2017-2032 (USD Million)
TABLE 265. North America Biotechnology Instrument Market Size, by Microarray Technology, 2017-2032 (USD Million)
TABLE 266. North America Biotechnology Instrument Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 267. North America Biotechnology Instrument Market Size, by Sequencing Technology, 2017-2032 (USD Million)
TABLE 268. North America Biotechnology Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. North America Biotechnology Instrument Market Size, by Cell Biology, 2017-2032 (USD Million)
TABLE 270. North America Biotechnology Instrument Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 271. North America Biotechnology Instrument Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 272. North America Biotechnology Instrument Market Size, by Genomics, 2017-2032 (USD Million)
TABLE 273. North America Biotechnology Instrument Market Size, by Proteomics, 2017-2032 (USD Million)
TABLE 274. North America Biotechnology Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. North America Biotechnology Instrument Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 276. North America Biotechnology Instrument Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 277. North America Biotechnology Instrument Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 278. Latin America Biotechnology Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 279. Latin America Biotechnology Instrument Market Size, by Instrument Type, 2017-2032 (USD Million)
TABLE 280. Latin America Biotechnology Instrument Market Size, by Cell Culture Systems, 2017-2032 (USD Million)
TABLE 281. Latin America Biotechnology Instrument Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 282. Latin America Biotechnology Instrument Market Size, by HPLC Systems, 2017-2032 (USD Million)
TABLE 283. Latin America Biotechnology Instrument Market Size, by Mass Spectrometers, 2017-2032 (USD Million)
TABLE 284. Latin America Biotechnology Instrument Market Size, by PCR Systems, 2017-2032 (USD Million)
TABLE 285. Latin America Biotechnology Instrument Market Size, by Sequencing Systems, 2017-2032 (USD Million)
TABLE 286. Latin America Biotechnology Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 287. Latin America Biotechnology Instrument Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 288. Latin America Biotechnology Instrument Market Size, by Flow Cytometry, 2017-2032 (USD Million)
TABLE 289. Latin America Biotechnology Instrument Market Size, by Microarray Technology, 2017-2032 (USD Million)
TABLE 290. Latin America Biotechnology Instrument Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 291. Latin America Biotechnology Instrument Market Size, by Sequencing Technology, 2017-2032 (USD Million)
TABLE 292. Latin America Biotechnology Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. Latin America Biotechnology Instrument Market Size, by Cell Biology, 2017-2032 (USD Million)
TABLE 294. Latin America Biotechnology Instrument Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 295. Latin America Biotechnology Instrument Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 296. Latin America Biotechnology Instrument Market Size, by Genomics, 2017-2032 (USD Million)
TABLE 297. Latin America Biotechnology Instrument Market Size, by Proteomics, 2017-2032 (USD Million)
TABLE 298. Latin America Biotechnology Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Latin America Biotechnology Instrument Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 300. Latin America Biotechnology Instrument Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 301. Latin America Biotechnology Instrument Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 302. Europe Biotechnology Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 303. Europe Biotechnology Instrument Market Size, by Instrument Type, 2017-2032 (USD Million)
TABLE 304. Europe Biotechnology Instrument Market Size, by Cell Culture Systems, 2017-2032 (USD Million)
TABLE 305. Europe Biotechnology Instrument Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 306. Europe Biotechnology Instrument Market Size, by HPLC Systems, 2017-2032 (USD Million)
TABLE 307. Europe Biotechnology Instrument Market Size, by Mass Spectrometers, 2017-2032 (USD Million)
TABLE 308. Europe Biotechnology Instrument Market Size, by PCR Systems, 2017-2032 (USD Million)
TABLE 309. Europe Biotechnology Instrument Market Size, by Sequencing Systems, 2017-2032 (USD Million)
TABLE 310. Europe Biotechnology Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 311. Europe Biotechnology Instrument Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 312. Europe Biotechnology Instrument Market Size, by Flow Cytometry, 2017-2032 (USD Million)
TABLE 313. Europe Biotechnology Instrument Market Size, by Microarray Technology, 2017-2032 (USD Million)
TABLE 314. Europe Biotechnology Instrument Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 315. Europe Biotechnology Instrument Market Size, by Sequencing Technology, 2017-2032 (USD Million)
TABLE 316. Europe Biotechnology Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. Europe Biotechnology Instrument Market Size, by Cell Biology, 2017-2032 (USD Million)
TABLE 318. Europe Biotechnology Instrument Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 319. Europe Biotechnology Instrument Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 320. Europe Biotechnology Instrument Market Size, by Genomics, 2017-2032 (USD Million)
TABLE 321. Europe Biotechnology Instrument Market Size, by Proteomics, 2017-2032 (USD Million)
TABLE 322. Europe Biotechnology Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Europe Biotechnology Instrument Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 324. Europe Biotechnology Instrument Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 325. Europe Biotechnology Instrument Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 326. Middle East Biotechnology Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 327. Middle East Biotechnology Instrument Market Size, by Instrument Type, 2017-2032 (USD Million)
TABLE 328. Middle East Biotechnology Instrument Market Size, by Cell Culture Systems, 2017-2032 (USD Million)
TABLE 329. Middle East Biotechnology Instrument Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 330. Middle East Biotechnology Instrument Market Size, by HPLC Systems, 2017-2032 (USD Million)
TABLE 331. Middle East Biotechnology Instrument Market Size, by Mass Spectrometers, 2017-2032 (USD Million)
TABLE 332. Middle East Biotechnology Instrument Market Size, by PCR Systems, 2017-2032 (USD Million)
TABLE 333. Middle East Biotechnology Instrument Market Size, by Sequencing Systems, 2017-2032 (USD Million)
TABLE 334. Middle East Biotechnology Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 335. Middle East Biotechnology Instrument Market Size, by Electrochemical Detection, 2017-2032 (USD Million)
TABLE 336. Middle East Biotechnology Instrument Market Size, by Flow Cytometry, 2017-2032 (USD Million)
TABLE 337. Middle East Biotechnology Instrument Market Size, by Microarray Technology, 2017-2032 (USD Million)
TABLE 338. Middle East Biotechnology Instrument Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 339. Middle East Biotechnology Instrument Market Size, by Sequencing Technology, 2017-2032 (USD Million)
TABLE 340. Middle East Biotechnology Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 341. Middle East Biotechnology Instrument Market Size, by Cell Biology, 2017-2032 (USD Million)
TABLE 342. Middle East Biotechnology Instrument Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 343. Middle East Biotechnology Instrument Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 344. Middle East Biotechnology Instrument Market Size, by Genomics, 2017-2032 (USD Million)
TABLE 345. Middle East Biotechnology Instrument Market Size, by Proteomics, 2017-2032 (USD Million)
TABLE 346. Middle East Biotechnology Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 347. Middle East Biotechnology Instrument Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 348. Middle East Biotechnology Instrument Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 349. Middle East Biotechnology Instrument Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 350. Africa Biotechnology Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 351. Africa Biotechnology Instrument Market Size, by Instrument Type, 2017-2032 (USD Million)
TABLE 352. Africa Biotechnology Instrument Market Size, by Cell Culture Systems, 2017-2032 (USD Million)
TABLE 353. Africa Biotechnology Instrument Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 354. Africa Biotechnology Instrument Market Size, by HPLC Systems, 2017-2032 (USD Million)
TABLE 355. Africa Biotechnology Instrument Market Size, by Mass Spectrometers, 2017-2032 (USD Million)
TABLE 356. Africa Biotechnology Instrument Market Size, by PCR Systems, 2017-2032 (USD Million)
TABLE 357. Africa Biotechnology Instrument Market Size, by Sequencing Systems, 2017-2032 (USD Million)
TABLE 358. Africa Biotechnology Instrument Ma

Companies Mentioned

  • Agilent Technologies, Inc.
  • Amgen Inc.
  • Bausch + Ströbel SE
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • QIAGEN N.V.
  • Revvity, Inc.
  • Sartorius AG
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation